LivFul Inc. — SEC Form D Filing

LivFul Inc. filed an SEC Form D on December 16, 2025, reporting $250K raised in Pharmaceuticals.

Form D filing details

Filing
SEC Form D
Filing date
December 16, 2025
Amount reported
$250K
Round stage
Pre-seed
Industry
Pharmaceuticals
Website
https://livful.com

Problem

Innovative and overlooked pharmaceutical intellectual property (IP) with global impact potential, particularly for non-opioid pain relief, wound healing, and treatments for diseases prevalent in the Global South, often lacks activation and development for these regions.

Solution

LivFul Inc. discovers and activates innovative and overlooked pharmaceutical IP, partners with local health systems in developing countries for early clinical validation, and then obtains regulatory approval for out-licensing to global north pharmaceutical partners and utilizes public/private partnerships for equitable distribution in the Global South.

Why now

LivFul is being started at this moment due to the behavioral shift of scientists being inspired to accelerate the global impact of their overlooked intellectual property, particularly for non-opioid pain relief or wound-healing compounds, in regions like the Global South where conventional drug development and distribution models are ineffective.

Source: SEC EDGAR Form D filing